NASDAQ:MRNA

Moderna Stock News

Healthcare > Biotechnology

Buy MRNA

*Your capital is at risk

$51.59

+2.53 (+5.16%)

At Close: Jun 04, 2026

Moderna R&D Day Highlights Progress and Strategic Priorities

06:00am, Thursday, 12'th Sep 2024

Focuses on ten product approvals through 2027 Expects to submit next-generation COVID vaccine for approval in 2024 Expects to submit flu/COVID combination vaccine for approval in 2024 Announces positi

Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNA

05:45am, Thursday, 12'th Sep 2024

NEW YORK , Sept. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Moderna, Inc. (NASDAQ: MRNA).

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

04:15am, Thursday, 12'th Sep 2024

These companies are innovators and either already have at least one commercialized product or are close to the finish line. One of these players has climbed this year, while the other two have decline

Levi & Korsinsky Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 – MRNA

05:45pm, Wednesday, 11'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f

Contact Levi & Korsinsky by October 8, 2024 Deadline to Join Class Action Against Moderna, Inc.(MRNA)

01:10pm, Wednesday, 11'th Sep 2024

NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit.

Investors who Lost Money on Moderna, Inc. (MRNA) Should Contact Levi & Korsinsky About Pending Class Action - MRNA

11:15am, Wednesday, 11'th Sep 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines – MRNA

11:00am, Wednesday, 11'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA) and certain officer

Moderna Inc Is Being Sued For Violating Securities Regulations And Stockholders Are Urged To Help The Schall Law Firm

11:00am, Wednesday, 11'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Moderna, Inc. (MRNA) Shareholders

07:15am, Wednesday, 11'th Sep 2024

MRNA Shareholders Have Opportunity to Lead Moderna, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

07:00am, Wednesday, 11'th Sep 2024

NEW YORK CITY, NY / ACCESSWIRE / September 11, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Modern

Shareholders That Lost Money on Moderna, Inc. (MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

04:15pm, Tuesday, 10'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

04:00pm, Tuesday, 10'th Sep 2024

NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by